| Year |
Citation |
Score |
| 2020 |
Texakalidis P, Tora MS, Federici T, Javidfar JJ, Boulis NM. Thoracoscopic delivery of therapeutics in the swine sympathetic chain: Implications for future neuromodulation. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 32336639 DOI: 10.1016/J.Jocn.2020.04.099 |
0.319 |
|
| 2020 |
Tora MS, Texakalidis P, Neill S, Wetzel J, Rindler RS, Hardcastle N, Nagarajan PP, Krasnopeyev A, Roach C, James R, Bruce JN, Canoll P, Federici T, Oshinski JN, Boulis NM. Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs. Scientific Reports. 10: 5291. PMID 32210315 DOI: 10.1038/S41598-020-62167-9 |
0.344 |
|
| 2019 |
O'Connor DM, Lutomski C, Jarrold MF, Boulis NM, Donsante A. Lot-to-lot Variation in Adeno-associated Virus Serotype 9 (AAV9) Preparations. Human Gene Therapy Methods. PMID 31752530 DOI: 10.1089/Hgtb.2019.105 |
0.309 |
|
| 2019 |
Texakalidis P, Tora MS, Nagarajan P, Keifer OP, Boulis NM. High cervical spinal cord stimulation for occipital neuralgia: a case series and literature review. Journal of Pain Research. 12: 2547-2553. PMID 31686897 DOI: 10.2147/Jpr.S214314 |
0.361 |
|
| 2019 |
Gross SK, Shim BS, Bartus RT, Deaver D, Mceachin Z, Betourne A, Boulis NM, Maragakis NJ. Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery. Experimental Neurology. 113091. PMID 31678350 DOI: 10.1016/J.Expneurol.2019.113091 |
0.395 |
|
| 2019 |
Texakalidis P, Tora MS, Canute S, Hardcastle N, Poth K, Donsante A, Federici T, Javidfar J, Boulis NM. Minimally Invasive Injection to the Phrenic Nerve in a Porcine Hemidiaphragmatic Paralysis Model: A Pilot Study. Neurosurgery. PMID 31625573 DOI: 10.1093/Neuros/Nyz473 |
0.392 |
|
| 2019 |
Anthony CL, Tora MS, Bentley JN, Texakalidis P, Boulis NM. Dorsal Root Ganglion Stimulation for Thoracic Neuralgia: A Report of Six Cases. Cureus. 11: e4615. PMID 31312542 DOI: 10.7759/Cureus.4615 |
0.314 |
|
| 2019 |
Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, ... ... Boulis NM, et al. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome. Stem Cells Translational Medicine. PMID 31104357 DOI: 10.1002/Sctm.18-0154 |
0.368 |
|
| 2019 |
Boulis NM. Intrathecal Riluzole for the Treatment of Patients With Amyotrophic Lateral Sclerosis Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_818 |
0.31 |
|
| 2019 |
Tora MS, Texakalidis P, Boulis NM. The Neurosurgeons' Armamentarium for the Management of Refractory Post-Herpetic Neuralgia Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_196 |
0.345 |
|
| 2018 |
Mlaver E, Keifer O, Tora MS, Campbell M, Boulis NM. Case Report: Phantom Sensation - An Underreported Sensory Outcome Following Intercostal-to-Musculocutaneous Nerve Transfer. World Neurosurgery. PMID 30415052 DOI: 10.1016/J.Wneu.2018.10.216 |
0.303 |
|
| 2018 |
Donsante A, Boulis NM. Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses. Expert Opinion On Biological Therapy. PMID 29936867 DOI: 10.1080/14712598.2018.1492544 |
0.362 |
|
| 2018 |
Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges L, Patil PG, Sakowski SA, Feldman EL. Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS. Annals of Clinical and Translational Neurology. 5: 730-740. PMID 29928656 DOI: 10.1002/Acn3.567 |
0.317 |
|
| 2017 |
Hardcastle N, Boulis NM, Federici T. AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials. Expert Opinion On Biological Therapy. 1-15. PMID 29249183 DOI: 10.1080/14712598.2018.1416089 |
0.408 |
|
| 2017 |
Squires A, Oshinski JN, Boulis NM, Tse ZTH. SpinoBot: An MRI-Guided Needle Positioning System for Spinal Cellular Therapeutics. Annals of Biomedical Engineering. PMID 29150766 DOI: 10.1007/S10439-017-1960-Z |
0.377 |
|
| 2017 |
Lamanna JJ, Gutierrez J, Espinosa JR, Wagner J, Urquia LN, Moreton C, Victor Hurtig C, Tora M, Kirk AD, Federici T, Boulis NM. Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29089163 DOI: 10.1016/J.Jocn.2017.10.033 |
0.315 |
|
| 2017 |
Keifer OP, Diaz A, Campbell M, Bezchlibnyk YB, Boulis NM. Occipital Nerve Stimulation for the Treatment of Refractory Occipital Neuralgia: A Case Series. World Neurosurgery. PMID 28634063 DOI: 10.1016/J.Wneu.2017.06.064 |
0.303 |
|
| 2017 |
Lamanna JJ, Gutierrez J, Urquia LN, Hurtig CV, Amador E, Grin N, Svendsen CN, Federici T, Oshinski JN, Boulis NM. Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging. Stem Cells Translational Medicine. 6: 139-150. PMID 28170192 DOI: 10.5966/Sctm.2015-0422 |
0.319 |
|
| 2017 |
Tora MS, Keifer OP, Lamanna JJ, Boulis NM. The challenges of developing a gene therapy for amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics. PMID 28132569 DOI: 10.1080/14737175.2017.1287565 |
0.307 |
|
| 2017 |
Lamanna JJ, Urquia LN, Hurtig CV, Gutierrez J, Anderson C, Piferi P, Federici T, Oshinski JN, Boulis NM. Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord. Stereotactic and Functional Neurosurgery. 95: 60-68. PMID 28132063 DOI: 10.1159/000448765 |
0.375 |
|
| 2016 |
Wagner JL, O'Connor DM, Donsante A, Boulis NM. Gene, Stem Cell, and Alternative Therapies for SCA 1. Frontiers in Molecular Neuroscience. 9: 67. PMID 27570504 DOI: 10.3389/Fnmol.2016.00067 |
0.333 |
|
| 2016 |
Gutierrez J, Federici T, Peterson B, Bartus R, Betourne A, Boulis NM. 321 Development of Intrathecal Riluzole: A New Route of Administration for the Treatment of Amyotrophic Lateral Sclerosis Patients. Neurosurgery. 63: 193. PMID 27399519 DOI: 10.1227/01.Neu.0000489810.52605.80 |
0.355 |
|
| 2016 |
Glass JD, Hertzberg VS, Boulis NM, Riley J, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, et al. Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials. Neurology. PMID 27358335 DOI: 10.1212/Wnl.0000000000002889 |
0.357 |
|
| 2016 |
Donsante A, McEachin Z, Riley J, Leung CH, Kanz L, O'Connor DM, Boulis NM. Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain. Gene Therapy. PMID 26824881 DOI: 10.1038/Gt.2016.6 |
0.533 |
|
| 2016 |
McEachin ZT, Donsante A, Boulis N. Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis. Methods in Molecular Biology (Clifton, N.J.). 1382: 399-408. PMID 26611602 DOI: 10.1007/978-1-4939-3271-9_28 |
0.359 |
|
| 2015 |
Levy M, Boulis N, Rao M, Svendsen CN. Regenerative cellular therapies for neurologic diseases. Brain Research. PMID 26239912 DOI: 10.1016/J.Brainres.2015.06.053 |
0.33 |
|
| 2015 |
Gutierrez J, Lamanna JJ, Grin N, Hurtig CV, Miller JH, Riley J, Urquia L, Avalos P, Svendsen CN, Federici T, Boulis NM. Preclinical Validation of Multilevel Intraparenchymal Stem Cell Therapy in the Porcine Spinal Cord. Neurosurgery. 77: 604-12. PMID 26134596 DOI: 10.1227/Neu.0000000000000882 |
0.369 |
|
| 2015 |
O'Connor DM, Boulis NM. Gene therapy for neurodegenerative diseases. Trends in Molecular Medicine. 21: 504-12. PMID 26122838 DOI: 10.1016/J.Molmed.2015.06.001 |
0.345 |
|
| 2015 |
Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L, Carletti S, Giorgi C, Spera C, Domenico F, Bersano E, Petruzzelli F, Cisari C, ... ... Boulis NM, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. Journal of Translational Medicine. 13: 17. PMID 25889343 DOI: 10.1186/S12967-014-0371-2 |
0.358 |
|
| 2015 |
Davis AS, Federici T, Ray WC, Boulis NM, O?Connor D, Clark KR, Bartlett JS. Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery. Neurosurgery. 76: 216-25; discussion 2. PMID 25549186 DOI: 10.1227/Neu.0000000000000589 |
0.401 |
|
| 2015 |
Gutierrez J, Moreton CL, Lamanna JJ, Schapiro R, Grin N, Hurtig CV, Miller JH, Riley J, Urquia L, Federici T, Boulis N. 203 Understanding Cell Migration After Direct Transplantation Into the Spinal Cord Neurosurgery. 62: 234. DOI: 10.1227/01.Neu.0000467124.38322.47 |
0.34 |
|
| 2014 |
Tadesse T, Gearing M, Senitzer D, Saxe D, Brat DJ, Bray R, Gebel H, Hill C, Boulis N, Riley J, Feldman E, Johe K, Hazel T, Polak M, Bordeau J, et al. Analysis of graft survival in a trial of stem cell transplant in ALS. Annals of Clinical and Translational Neurology. 1: 900-8. PMID 25540804 DOI: 10.1002/Acn3.134 |
0.362 |
|
| 2014 |
Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Annals of Neurology. 75: 363-73. PMID 24510776 DOI: 10.1002/Ana.24113 |
0.36 |
|
| 2014 |
Keifer OP, O'Connor DM, Boulis NM. Gene and protein therapies utilizing VEGF for ALS. Pharmacology & Therapeutics. 141: 261-71. PMID 24177067 DOI: 10.1016/J.Pharmthera.2013.10.009 |
0.3 |
|
| 2014 |
Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, Johe K, Boulis NM. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery. 74: 77-87. PMID 24018694 DOI: 10.1227/Neu.0000000000000156 |
0.346 |
|
| 2013 |
Lamanna JJ, Miller JH, Riley JP, Hurtig CV, Boulis NM. Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application. Therapeutic Delivery. 4: 1397-410. PMID 24228990 DOI: 10.4155/Tde.13.111 |
0.38 |
|
| 2013 |
Bethoux F, Boulis N, McClelland S, Willis MA, Hussain M, Machado A, Mychkovsky L, Stough D, Sutliff M, Pioro EP. Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease. Neurorehabilitation and Neural Repair. 27: 828-33. PMID 23884016 DOI: 10.1177/1545968313496325 |
0.344 |
|
| 2013 |
Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, Vandenberghe LH, Wilson TJ, Wolfe JH, Glorioso JC. Progress in gene therapy for neurological disorders. Nature Reviews. Neurology. 9: 277-91. PMID 23609618 DOI: 10.1038/Nrneurol.2013.56 |
0.341 |
|
| 2013 |
Boulis NM, Handy CR, Krudy CA, Donnelly EM, Federici T, Franz CK, Barrow EM, Teng Q, Kumar P, Cress D. Regulated neuronal neuromodulation via spinal cord expression of the gene for the inwardly rectifying potassium channel 2.1 (Kir2.1). Neurosurgery. 72: 653-61; discussion 6. PMID 23277370 DOI: 10.1227/Neu.0B013E318283F59A |
0.704 |
|
| 2012 |
Lamanna JJ, Donnelly EM, Oshinski JN, Boulis NM, Federici T. 177 Pre-clinical Validation of Superparamagnetic Iron Oxide Nanoparticle-Labeled Neural Stem Cells for In Vivo Tracking and Post-Mortem Identification in the Spinal Cord. Neurosurgery. 71: E569. PMID 28175756 DOI: 10.1227/01.Neu.0000417765.10193.04 |
0.305 |
|
| 2012 |
Federici T, Hurtig CV, Burks KL, Riley JP, Krishna V, Miller BA, Sribnick EA, Miller JH, Grin N, Lamanna JJ, Boulis NM. Surgical technique for spinal cord delivery of therapies: demonstration of procedure in gottingen minipigs. Journal of Visualized Experiments : Jove. e4371. PMID 23242422 DOI: 10.3791/4371 |
0.383 |
|
| 2012 |
Riley J, Taub J, Raore B, Boulis NM. An overview of domestic and international clinical trials for delivery of cellular therapies to the spinal cord. Clinical Neurosurgery. 59: 98-104. PMID 22960520 DOI: 10.1227/Neu.0B013E31826B2Eee |
0.357 |
|
| 2012 |
Donnelly EM, Boulis NM. Update on gene and stem cell therapy approaches for spinal muscular atrophy. Expert Opinion On Biological Therapy. 12: 1463-71. PMID 22849423 DOI: 10.1517/14712598.2012.711306 |
0.399 |
|
| 2012 |
Donnelly EM, Lamanna J, Boulis NM. Stem cell therapy for the spinal cord. Stem Cell Research & Therapy. 3: 24. PMID 22776143 DOI: 10.1186/Scrt115 |
0.379 |
|
| 2012 |
O'Connor DM, Boulis NM. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy. Neuroscience Letters. 527: 78-84. PMID 22579818 DOI: 10.1016/J.Neulet.2012.04.079 |
0.408 |
|
| 2012 |
Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, Taub J, Kesner V, Feldman EL, Boulis NM. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery. 71: 405-16; discussion 4. PMID 22565043 DOI: 10.1227/Neu.0B013E31825Ca05F |
0.404 |
|
| 2012 |
Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells (Dayton, Ohio). 30: 1144-51. PMID 22415942 DOI: 10.1002/Stem.1079 |
0.395 |
|
| 2012 |
Donnelly EM, Quach ET, Hillery TM, Heeke BL, Snyder BR, Handy CR, O'Connor DM, Boulis NM, Federici T. Characterization of a murine model of SMA. Neurobiology of Disease. 45: 992-8. PMID 22198571 DOI: 10.1016/J.Nbd.2011.12.018 |
0.392 |
|
| 2012 |
Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA, Samulski RJ, Boulis NM. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Therapy. 19: 852-9. PMID 21918551 DOI: 10.1038/Gt.2011.130 |
0.427 |
|
| 2012 |
Federici T, Boulis NM. Gene therapy for amyotrophic lateral sclerosis. Neurobiology of Disease. 48: 236-42. PMID 21889591 DOI: 10.1016/J.Nbd.2011.08.018 |
0.357 |
|
| 2012 |
Riley J, Hurtig CV, Boulis N. Translating cellular therapies from bench to bedside for amyotrophic lateral sclerosis Personalized Medicine. 9: 645-655. DOI: 10.2217/Pme.12.74 |
0.319 |
|
| 2011 |
Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL. Translational stem cell therapy for amyotrophic lateral sclerosis. Nature Reviews. Neurology. 8: 172-6. PMID 22158518 DOI: 10.1038/Nrneurol.2011.191 |
0.328 |
|
| 2011 |
Kliem MA, Heeke BL, Franz CK, Radovitskiy I, Raore B, Barrow E, Snyder BR, Federici T, Kaye Spratt S, Boulis NM. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 331-9. PMID 21864053 DOI: 10.3109/17482968.2011.574142 |
0.682 |
|
| 2011 |
Leung CH, Kliem MA, Heeke BL, McPhee SW, Federici T, Snyder BR, Boulis NM. Assessment of hippocampal adeno-associated viral vector gene delivery via frameless stereotaxis in a nonhuman primate. Stereotactic and Functional Neurosurgery. 89: 275-85. PMID 21849811 DOI: 10.1159/000328265 |
0.527 |
|
| 2011 |
Boulis N, Federici T. Surgical approach and safety of spinal cord stem cell transplantation Neurosurgery. 68: E599-E600. PMID 21654562 DOI: 10.1227/Neu.0B013E3182095E2E |
0.341 |
|
| 2011 |
Riley JP, Raore B, Taub JS, Federici T, Boulis NM. Platform and cannula design improvements for spinal cord therapeutics delivery. Neurosurgery. 69: ons147-54; discussio. PMID 21471842 DOI: 10.1227/Neu.0B013E3182195680 |
0.37 |
|
| 2011 |
Snyder BR, Gray SJ, Quach ET, Huang JW, Leung CH, Samulski RJ, Boulis NM, Federici T. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Human Gene Therapy. 22: 1129-35. PMID 21443428 DOI: 10.1089/Hum.2011.008 |
0.589 |
|
| 2011 |
Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Stem cell technology for the study and treatment of motor neuron diseases. Regenerative Medicine. 6: 201-13. PMID 21391854 DOI: 10.2217/Rme.11.6 |
0.354 |
|
| 2011 |
Raore B, Federici T, Taub J, Wu MC, Riley J, Franz CK, Kliem MA, Snyder B, Feldman EL, Johe K, Boulis NM. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine. 36: E164-71. PMID 21099736 DOI: 10.1097/Brs.0B013E3181D77A47 |
0.718 |
|
| 2011 |
Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Erratum: Stem cell technology for the study and treatment of motor neuron diseases, which appeared in the February issue of Regenerative Medicine (Regen. Med. (2011) 6:2 (201-213)) Regenerative Medicine. 6. DOI: 10.2217/Rme.11.30 |
0.32 |
|
| 2010 |
Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4 |
0.321 |
|
| 2010 |
Snyder BR, Boulis NM, Federici T. Viral vector-mediated gene transfer for CNS disease. Expert Opinion On Biological Therapy. 10: 381-94. PMID 20132059 DOI: 10.1517/14712590903514074 |
0.339 |
|
| 2009 |
Federici T, Riley J, Park J, Bain M, Boulis NM. Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord Clinical and Translational Science. 2: 165-167. PMID 20443884 DOI: 10.1111/J.1752-8062.2008.00084.X |
0.385 |
|
| 2009 |
Federici T, Boulis NM. Invited review: festschrift edition of neurosurgery peripheral nervous system as a conduit for delivering therapies for diabetic neuropathy, amyotrophic lateral sclerosis, and nerve regeneration. Neurosurgery. 65: A87-92. PMID 19927084 DOI: 10.1227/01.Neu.0000335653.52938.F2 |
0.344 |
|
| 2009 |
Riley J, Federici T, Park J, Suzuki M, Franz CK, Tork C, McHugh J, Teng Q, Svendsen C, Boulis NM. Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Neurosurgery. 65: 754-61; discussion 7. PMID 19834381 DOI: 10.1227/01.Neu.0000343524.45387.9E |
0.687 |
|
| 2009 |
Franz CK, Quach ET, Krudy CA, Federici T, Kliem MA, Snyder BR, Raore B, Boulis NM. A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis. Plos One. 4: e7357. PMID 19806196 DOI: 10.1371/Journal.Pone.0007357 |
0.678 |
|
| 2009 |
Federici T, Kutner R, Zhang XY, Kuroda H, Tordo N, Boulis NM, Reiser J. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer. Genetic Vaccines and Therapy. 7: 1. PMID 19144125 DOI: 10.1186/1479-0556-7-1 |
0.383 |
|
| 2009 |
Franz CK, Federici T, Yang J, Backus C, Oh SS, Teng Q, Carlton E, Bishop KM, Gasmi M, Bartus RT, Feldman EL, Boulis NM. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS. Neurobiology of Disease. 33: 473-81. PMID 19135533 DOI: 10.1016/J.Nbd.2008.12.003 |
0.712 |
|
| 2009 |
Federici T, Riley J, Boulis N. Gene-Based Neuromodulation Neuromodulation. 1: 131-141. DOI: 10.1016/B978-0-12-374248-3.00014-8 |
0.338 |
|
| 2008 |
Carlton E, Teng Q, Federici T, Yang J, Riley J, Boulis NM. Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons. Neurosurgery. 63: 1175-82; discussion . PMID 19057331 DOI: 10.1227/01.Neu.0000334415.45003.Ea |
0.36 |
|
| 2008 |
Riley J, Sweeney W, Boulis N. Shifting the balance: cell-based therapeutics as modifiers of the amyotrophic lateral sclerosis-specific neuronal microenvironment. Neurosurgical Focus. 24: E10. PMID 18341386 DOI: 10.3171/Foc/2008/24/3-4/E9 |
0.335 |
|
| 2008 |
Riley J, Butler J, Baker KB, McClelland S, Teng Q, Yang J, Garrity-Moses M, Federici T, Boulis NM. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotactic and Functional Neurosurgery. 86: 67-74. PMID 18073518 DOI: 10.1159/000112426 |
0.385 |
|
| 2007 |
Federici T, Boulis N. Gene therapy for peripheral nervous system diseases. Current Gene Therapy. 7: 239-48. PMID 17969557 DOI: 10.2174/156652307781369083 |
0.345 |
|
| 2007 |
Yang J, Teng Q, Garrity-Moses ME, McClelland S, Federici T, Carlton E, Riley J, Boulis NM. Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra. Neuromolecular Medicine. 9: 276-84. PMID 17914186 DOI: 10.1007/S12017-007-8003-0 |
0.306 |
|
| 2007 |
Alexopoulos AV, Gonugunta V, Yang J, Boulis NM. Electrical stimulation and gene-based neuromodulation for control of medically-refractory epilepsy. Acta Neurochirurgica. Supplement. 97: 293-309. PMID 17691316 DOI: 10.1007/978-3-211-33081-4_33 |
0.307 |
|
| 2007 |
Federici T, Liu JK, Teng Q, Yang J, Boulis NM. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage. Neurosurgery. 60: 911-8; discussion 91. PMID 17460527 DOI: 10.1227/01.Neu.0000255444.44365.B9 |
0.36 |
|
| 2007 |
McClelland S, Teng Q, Benson LS, Boulis NM. Motor neuron inhibition-based gene therapy for spasticity. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 86: 412-21. PMID 17449986 DOI: 10.1097/Phm.0B013E31804A83Cf |
0.394 |
|
| 2007 |
Federici T, Boulis NM. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches. Neurosurgery. 60: 3-15; discussion 15-. PMID 17228249 DOI: 10.1227/01.Neu.0000249214.42461.A5 |
0.312 |
|
| 2007 |
Yang J, Teng Q, Federici T, Najm I, Chabardes S, Moffitt M, Alexopoulos A, Riley J, Boulis NM. Viral clostridial light chain gene-based control of penicillin-induced neocortical seizures. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 542-51. PMID 17213837 DOI: 10.1038/Sj.Mt.6300069 |
0.313 |
|
| 2006 |
Garrity-Moses ME, Teng Q, Krudy C, Yang J, Federici T, Boulis NM. X-Linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system. Neurosurgery. 59: 172-82; discussion 1. PMID 16823314 DOI: 10.1227/01.Neu.0000219237.69329.B7 |
0.348 |
|
| 2006 |
Zhao Z, Krishnaney A, Teng Q, Yang J, Garrity-Moses M, Liu JK, Venkiteswaran K, Subramanian T, Davis M, Boulis NM. Anatomically discrete functional effects of adenoviral clostridial light chain gene-based synaptic inhibition in the midbrain. Gene Therapy. 13: 942-52. PMID 16511525 DOI: 10.1038/Sj.Gt.3302733 |
0.445 |
|
| 2006 |
Federici T, Boulis NM. Gene-based treatment of motor neuron diseases. Muscle & Nerve. 33: 302-23. PMID 16228969 DOI: 10.1002/Mus.20439 |
0.406 |
|
| 2006 |
Teng Q, Bartlett J, Federici T, Yang J, Boulis N. 500. Tetanus Toxin Heavy Chain-Streptoavidin Fusion Protein for Targeted Motor Neuron Gene Delivery through Metabolically Biotinylated AAV Molecular Therapy. 13: S193. DOI: 10.1016/J.Ymthe.2006.08.570 |
0.34 |
|
| 2006 |
Yang J, Teng Q, Garrity-Moses ME, Federici T, Butler J, McClelland S, Boulis NM. 240. Hemiparkisonism Induced through Unilateral Expression of Adenovirus-Mediated Clostridial Light Chain Gene in the Substantia Nigra Molecular Therapy. 13: S92. DOI: 10.1016/J.Ymthe.2006.08.267 |
0.301 |
|
| 2005 |
Garrity-Moses ME, Teng Q, Liu J, Tanase D, Boulis NM. Neuroprotective adeno-associated virus Bcl-xL gene transfer in models of motor neuron disease. Muscle & Nerve. 32: 734-44. PMID 16116646 DOI: 10.1002/Mus.20418 |
0.356 |
|
| 2005 |
Liu JK, Teng Q, Garrity-Moses M, Federici T, Tanase D, Imperiale MJ, Boulis NM. A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting. Neurobiology of Disease. 19: 407-18. PMID 16023583 DOI: 10.1016/J.Nbd.2005.01.022 |
0.309 |
|
| 2005 |
Teng Q, Garrity-Moses M, Federici T, Tanase D, Liu JK, Mazarakis ND, Azzouz M, Walmsley LE, Carlton E, Boulis NM. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro. Neurobiology of Disease. 20: 694-700. PMID 16005636 DOI: 10.1016/J.Nbd.2005.05.016 |
0.34 |
|
| 2005 |
Teng Q, Tanase D, Tanase DK, Liu JK, Garrity-Moses ME, Baker KB, Boulis NM. Adenoviral clostridial light chain gene-based synaptic inhibition through neuronal synaptobrevin elimination. Gene Therapy. 12: 108-19. PMID 15496959 DOI: 10.1038/Sj.Gt.3302400 |
0.386 |
|
| 2005 |
Federici T, Liu JK, Teng Q, Garrity-Moses M, Yang J, Boulis NM. 855. In Vivo Spinal Cord Uptake and Neuronal Binding Properties of Tet1: A Potential Means for Enhanced Spinal Cord AAV Delivery Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.398 |
0.359 |
|
| 2005 |
Davis A, Stachler M, Shi W, Liu J, Boulis N, Bartlett J. 113. Manipulating AAV2 Tropism for Enhanced Delivery of AAV Vectors to the Spinal Cord Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.118 |
0.422 |
|
| 2004 |
Vincent AM, Feldman EL, Song DK, Jung V, Schild A, Zhang W, Imperiale MJ, Boulis NM. Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro. Neuromolecular Medicine. 6: 79-85. PMID 15970625 DOI: 10.1385/Nmm:6:2-3:079 |
0.377 |
|
| 2004 |
Tanase K, Teng Q, Krishnaney AA, Liu JK, Garrity-Moses ME, Boulis NM. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. Journal of Neurosurgery. Spine. 1: 128-36. PMID 15291033 DOI: 10.3171/Spi.2004.1.1.0128 |
0.404 |
|
| 2004 |
Teng Q, Garrity-Moses M, Liu JK, Tanase D, Azzouz M, Walmsley L, Mazarakis ND, Boulis NM. 735. EIAV-IGF-I Gene Transfer to Motor Neurons Enhances Axonal Length In Vitro Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.679 |
0.393 |
|
| 2004 |
Tanase D, Teng Q, Krishnaney AA, Liu JK, Garrity-Moses ME, Mazarakis N, Walmsley LE, Azzouz M, Boulis NM. 532. Cervical Spinal Cord Delivery of a Lentiviral Vector in SOD-1 Transgenic Mice Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.479 |
0.418 |
|
| 2004 |
Krishnaney AA, Zhao Z, Teng Q, Liu J, Tenase D, Garrity-Moses M, Davis M, Boulis NM. 45. Adenoviral tetanus toxin light chain gene expression in the brainstem induces specific motor inhibition Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.067 |
0.449 |
|
| 2003 |
Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiology of Disease. 14: 535-41. PMID 14678769 DOI: 10.1016/J.Nbd.2003.08.025 |
0.411 |
|
| 2003 |
Garrity-Moses ME, Liu JK, Boulis NM. Molecular biology and gene therapy in the treatment of chronic pain. Neurosurgery Clinics of North America. 14: 419-35. PMID 14567143 DOI: 10.1016/S1042-3680(03)00008-1 |
0.338 |
|
| 2003 |
Rubin A, Mobley B, Hogikyan N, Bell K, Sullivan K, Boulis N, Feldman E. Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve. The Laryngoscope. 113: 985-9. PMID 12782809 DOI: 10.1097/00005537-200306000-00013 |
0.331 |
|
| 2003 |
Boulis NM, Willmarth NE, Song DK, Feldman EL, Imperiale MJ. Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery. Neurosurgery. 52: 381-7; discussion 38. PMID 12535368 DOI: 10.1227/01.Neu.0000044459.24519.3E |
0.387 |
|
| 2002 |
Boulis NM, Turner DE, Imperiale MJ, Feldman EL. Neuronal survival following remote adenovirus gene delivery. Journal of Neurosurgery. 96: 212-9. PMID 12450285 DOI: 10.3171/Spi.2002.96.2.0212 |
0.407 |
|
| 2001 |
Turner DE, Noordmans AJ, Feldman EL, Boulis NM. Remote adenoviral gene delivery to the spinal cord: contralateral delivery and reinjection. Neurosurgery. 48: 1309-16; discussion . PMID 11383735 DOI: 10.1097/00006123-200106000-00026 |
0.398 |
|
| 1999 |
Boulis NM, Turner DE, Dice JA, Bhatia V, Feldman EL. Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery. 45: 131-7; discussion 13. PMID 10414575 DOI: 10.1097/00006123-199907000-00029 |
0.397 |
|
| 1999 |
Boulis NM, Bhatia V, Brindle TI, Holman HT, Krauss DJ, Blaivas M, Hoff JT. Adenoviral nerve growth factor and beta-galactosidase transfer to spinal cord: a behavioral and histological analysis. Journal of Neurosurgery. 90: 99-108. PMID 10413133 DOI: 10.3171/Spi.1999.90.1.0099 |
0.399 |
|
| 1991 |
Kehne JH, Boulis NM, Davis M. Effects of the phosphodiesterase inhibitor rolipram on the acoustic startle response in rats. Psychopharmacology. 105: 27-36. PMID 1660609 DOI: 10.1007/Bf02316860 |
0.455 |
|
| 1990 |
Boulis NM, Davis M. Blockade of the spinal excitatory effect of cAMP on the startle reflex by intrathecal administration of the isoquinoline sulfonamide H-8: comparison to the protein kinase C inhibitor H-7. Brain Research. 525: 198-204. PMID 2174710 DOI: 10.1016/0006-8993(90)90864-8 |
0.402 |
|
| 1990 |
Boulis NM, Kehne JH, Miserendino MJ, Davis M. Differential blockade of early and late components of acoustic startle following intrathecal infusion of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or D,L-2-amino-5-phosphonovaleric acid (AP-5). Brain Research. 520: 240-6. PMID 1976408 DOI: 10.1016/0006-8993(90)91711-O |
0.407 |
|
| 1989 |
Davis M, Commissaris RL, Yang S, Wagner KR, Kehne JH, Cassella JV, Boulis NM. Spinal vs. supraspinal sites of action of the alpha 2-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex. Pharmacology, Biochemistry, and Behavior. 33: 233-40. PMID 2571168 DOI: 10.1016/0091-3057(89)90455-3 |
0.401 |
|
| 1989 |
Boulis NM, Davis M. Footshock-induced sensitization of electrically elicited startle reflexes. Behavioral Neuroscience. 103: 504-508. PMID 2544200 DOI: 10.1037//0735-7044.103.3.504 |
0.427 |
|
| Show low-probability matches. |